JSR Corp. (TYO:4185) is working on the Japanese launch of pre-clinical trial services that utilize cancer organoids, which are tumor-derived…...
Pharma
Asahi Kasei Targets Sales of 1 Trillion Yen in Health Care Sector
Asahi Kasei Corp. (TYO:3407) is pursuing a growth strategy for its Health Care sector, with aims here being to achieve…...
Sumitomo Dainippon Pharma to Expand Regenerative and Cellular Medicine CDMO Operations
Sumitomo Dainippon Pharma Co. Ltd. (TYO:4506) and Sumitomo Chemical Co. Ltd. (TYO:4005) plan to expand their CDMO facilities for regenerative…...